Cell function is significantly influenced by a process called ubiquitination, in which molecules are selected for elimination ...

Clinical researchers at King George’s Medical University and Sanjay Gandhi Post Graduate Institute of Medical Sciences have ...

A fat-producing enzyme in brain cells may play a key role in driving damage in Parkinson's disease and could offer a new ...

A review in Glycoscience & Therapy summarizes advances in selective editing of N-glycan signals on living cell surface via the LCS‑NGS technology platform. It focuses on enzyme‑based strategies ...

Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses ...

Is, used to treat Parkinson's disease, affect the gut microbiota, leading to levodopa degradation before it reaches the brain ...

Researchers have identified a specific enzyme inside drug-resistant E. coli that bacteria need to build the tiny, hair-like ...

Axsome obtains exclusive global rights to balipodect, a potentially first-in-class selective phosphodiesterase 10A inhibitorAcquisition further ...

First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage diseaseFirst FDA-approved ...

Bayer advances AB-1002 after AskBio completes mid-stage study enrollment, as its Pharma strategy and pipeline milestones drive long-term growth outlook.

FRANKFURT - Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm Synnovation Therapeutics, adding a targeted therapy to its ...